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Neutrophil-surface antigens CD11b and CD64 expression: a potential 
predictor of early-onset neonatal sepsis 
 
INTRODUCTION 
Sepsis neonatorum is a life-threatening disease that 
remains a major cause of morbidity and mortality in 
the newborn1, mainly among preterm and low birth 
weight (LBW) infants2. Early recognition and 
implementation of appropriate therapy offers the 
best outcome, and careful assessment of the 
newborn is essential. 
Early-onset sepsis presents a fulminant multi-
system illness during the first days of life. It mostly 
occurs in newborn infants with one or more 
obstetric complication including premature rupture 
of membranes (PROM) 3, premature onset of labor4, 
chorioamnionitis5, or peripartum maternal fever6. 
Early detection of neonatal sepsis is difficult as the 
clinical signs are subtle, non-specific and 
indistinguishable from those caused by a variety of 
neonatal non-infective disorders such as aspiration 
syndrome, maladaptation and respiratory distress 
syndrome. It is therefore recommended for all 
neonates who develop these signs to start empirical 
antimicrobial therapy1. This clinical practice, 
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Background: CD11b, an α subunit of the β2 integrin adhesion molecule, and 
CD64, the high affinity Fcγ receptor I, are specific neutrophil-surface 
antigens activated in response to systemic inflammation and, hence, they 
might potentially help identifying neonatal infections. 
Objective: We sought to evaluate the time course of expression and 
diagnostic and prognostic utility of CD11b and CD64 in early-onset sepsis 
in the suspected newborn. 
Methods: Sixty newborn infants (28-40 weeks gestation) with antenatal risk 
factors for sepsis were enrolled and subjected to sepsis work-up including 
complete blood count, quantification of serum C reactive protein (CRP) and 
flow cytometric analysis of CD11b and CD64 in cord blood (0 h). These 
tests were repeated at 8, 24 and 48 h postnatally. Neonates were defined, 
retrospectively, in two groups: sepsis and no infection, on basis of clinical 
observation over their first five postnatal days and sepsis work-up results.  
Results: A significant enhancement of neutrophil CD11b and CD64 
expression was demonstrated in the sepsis group as compared to the non-
infected group. CD11b over-expression had an onset at 0 h. Its mean value 
approached two-fold mean level of non-infected neonates by 8-24 h, and 
declined thereafter. CD64 rising onset was detectable at 8 h and its mean 
percentage reached four-fold mean value of the non-infected group at 24 h. 
At 24 h, an optimal cut-off value for CD11b expression of 35% (sensitivity 
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88%, and specificity 90.3%) had the best performance for prediction of 
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fatal outcome. At 24 h, a cut-off value of 88% expression for CD11b and 
50% expression for CD64 predicted mortality with sensitivity and specificity 
of 100%.  
Conclusion: Enhanced expression of neutrophil-surface antigens CD11b 
and CD64 could be a promising tool for prediction and therapeutic 
decision-making in early-onset sepsis indicating the necessity of initiation of 
antimicrobial therapy and reduction of its unnecessary use in non-infected 
neonates even before definitive microbiologic identification. 
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however, renders many neonates unduly susceptible 
to side effects of antimicrobial agents, increases 
hospital costs and promotes development and 
spread of resistant bacterial strains. Hence, there 
remains a requirement for an efficient marker that 
can reliably predict and identify truly infected 
neonates, and exclude infection in suspected, but 
non-infected, infants. 
An important early event in sepsis is the 
generation and release of cytokines by immune 
cells in response to invasion by bacteria and their 
toxins7. These cytokines induce activation of 
leucocytes, the primary function of which is to 
eliminate invading microorganisms8. During 
neutrophil activation, surface adhesion molecules 
including L-selectin9, CD43, CD4410 and CD5011 
are expressed and cleaved from neutrophil cell 
surface, down-regulating their expression on 
activated neutrophils11,12. In contrast, the leucocyte 
integrin Mac-1 (CD11b/CD18) and the high affinity 
Fcγ receptor I (CD64) behave as activation antigens 
on neutrophils, increasing their expression on the 
surface of the cell after its activation and hence, are 
considered as specific neutrophil-surface activation 
markers10. Activation of CD11b, an α subunit of the 
β2 integrin adhesion molecule,  and CD64 surface 
antigens expression had been shown by neonatal 
neutrophils to an extent similar to those of older 
children and adults, thus they could potentially be 
used for identification of neonatal life-threatening 
infections13. 
This study is aimed to delineate the time course 
and pattern of expression of the neutrophil-surface 
activation markers CD11b and CD64 as 
immunological indicators of inflammatory response 
to infection in neonates suspected for early-onset 
sepsis, and to establish their diagnostic and 
prognostic utilities during the first 48 hours of 
postnatal life.   
  
METHODS 
The study series comprised 60 newborn infants with 
gestational ages of 28 to 40 weeks and birth weights 
between 1500 and 4100 gm, delivered at the 
Maternity Hospital of Ain Shams University, Cairo, 
Egypt. They were transferred to the Neonatal 
Intensive Care Unit (NICU) of the hospital because 
of having at least one risk factor for suspicion of 
neonatal sepsis (prolonged premature rupture of 
membranes >24 h, premature onset of labor, 
chorioamnionitis or  peripartum maternal fever). 
Clinical symptoms and signs suggesting infection in 
the early neonatal period (first 5 postnatal days), as 
recorded by medical and nursing staff members in 
the NICU, were divided into the following 
categories: 
• Temperature instability (hypothermia, 
hyperthermia) 
• Respiratory distress (grunting, intercostals 
retractions, apnea, cyanosis) 
• Cardiovascular (tachycardia, bradycardia, poor 
perfusion, shock) 
• Neurologic (hypotonia, lethargy, sluggish Moro 
reflex) 
• Gastrointestinal (feeding intolerance, abdominal 
distension) 
Blood samples were withdrawn immediately at 
birth from cord blood (0 h) and were repeated at 8, 
24 and 48 h of postnatal age from peripheral blood 
for determination of: 
• Complete blood counts (CBC) using Coulter Max 
M Counter (Coulter Corporation, Miami, Florida 
33196, USA) 
• Semi-quantitative measurement of serum CRP 
concentration, using kits supplied by Behring 
Diagnostics (GmbH, Marburg, Germany) 
• Expression of CD11b and CD64 on neutrophil 
surface by flow cytometry (Epics profile II 
Coulter) using DAKO monoclonal antibodies 
(Glosture, Denmark) 
One sample for each neonate was obtained for 
blood culture (requested at the age of 0-48 hours) 
applying the BACTEC 9050 system (Becton 
Dickenson Microbiology System, 7 Loventon 
circle, Sparks, Maryland 21152) 
The neonates were assigned retrospectively, on 
the basis of clinical observation over their first 5 
postnatal days and sepsis work-up results, into 2 
groups: 
1. Sepsis group (n=29): clinical sepsis developed (3 
or more clinical signs of infection, hematological 
scoring for sepsis14 ≥3, CRP >12 mg/L, with or 
without positive blood culture results). They were 
15 males and 14 females; 18 (62%) were 
delivered vaginally and 11 (38%) by cesarean 
section. They had a mean gestational age of 
35.3±3.54 weeks, and a mean birth weight of 
2700±680 gm. 
2. No infection (non-septic) group (n=31): infection 
was ruled out on both clinical and laboratory 
basis. They were 17 males and 14 females; 
25(81%) were delivered vaginally, and 6(19%) by 
cesarean section. Their mean gestational age was 
37.9±0.95 weeks; and mean birth weight was 
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Procedure of blood sampling:  
for each neonate of the study, two milliliters of 
blood were collected at birth (0 h) and at 8, 24, and 
48 h of postnatal life. Each sample was divided in 
two tubes. The first tube contained K-EDTA as an 
anticoagulant. Blood in this tube was used for 
complete blood count and flow cytometric analysis 
of neutrophil surface markers. The second tube was 
a plain tube in which blood was left to clot and 
serum was separated for CRP determination. 
 
Procedure of Flow cytometric analysis: 
Flow cytometric analysis was performed on 
EPICS–XL Coulter Flow Cytometer using 
flourescein isothiocyanate (FITC)-labeled anti-
CD64 and phycoerythrin (PE)-labeled anti-CD11b 
together with their specific isotypic control reagents 
within 24 hours of collection. All monoclonal 
antibodies were purchased from Becton Dickinson 
(Mountain View, CA., USA). The collected blood 
was incubated with each of the two monoclonal 
antibodies for 30 minutes at room temperature. 
Erythrocytes were lysed by adding a lysing solution 
(ammonium chloride 0.85 % buffered with 
potassium bicarbonate pH 7.2) for 5 minutes at 
37οC. Finally, the samples were washed with 
phosphate buffer saline (PBS) prior to flow 
cytometric analysis. The neutrophils were 
specifically analyzed by selective gating based on 
the parameters of forward and side scatter (Fig I 
and II).  
 
Statistical analysis: 
Data were statistically analyzed using SPSS 
software version under Windows 98. The results are 
expressed as mean values ± standard deviation 
(SD). Student t test was applied for comparisons 
between groups. For non-parametric data, Wilcoxon 
rank-sum test was applied. Correlation of different 
parameters was done using Spearman correlation 
coefficient (r) taking the probability (p) level of 
significance at <0.05. The diagnostic performance 
of CD11b and CD64 was assessed  using the  
receiver operator characteristic (ROC) curve 




There was no significant difference between sepsis 
and no infection groups in terms of sex distribution 
and delivery modalities (p>0.05). Septic neonates, 
however, were found to have a significantly lower 
mean gestational age (p<0.01) and mean birth 
weight (p<0.05) as compared to the non-septic 
group. 
In the group of sepsis, 93% had hematological 
scores of ≥3 over the study period. Positive blood 
cultures for bacteria were encountered in 22 
(75.8%) of cases. Most of the blood cultures 
demonstrated the presence of E.coli (27.6%), 
Klebsiella pneumoniae (24.1%) or mixed infection 
with both microbes (7%).  
Serial determinations of CRP levels revealed that 
all 29 neonates who developed early-onset sepsis 
had negative initial CRP in cord blood. Peak CRP 
concentrations remained ≤12 mg/L in 27(93%) at 8 
h, and in 15(51.7%) at 24 h with corresponding 
diagnostic sensitivities of 3.57% and 40% 
respectively. By 48 h, CRP diagnostic sensitivity 
for sepsis was 85.7%. 
Early significant increase in mean percentage of 
CD11b expression was detected in cord blood 
samples (0 h) from neonates who developed sepsis 
as compared to the non-infected group (p<0.05). 
Progressive  increase in mean CD11b expression in 
sepsis group was subsequently observed in samples 
obtained at 8 and 24 h (p<0.001, respectively) and 
started to decline thereafter (Table 1 & Fig 1A). 
On the other hand, mean percentage of 
neutrophil CD64 expression did not show 
significant difference between sepsis and no 
infection groups in initial samples obtained from 
cord blood (p>0.05). Progressive significant 
increases in mean CD64 expression in sepsis group 
in comparison to non-infected neonates, were 
observed in subsequent blood samples obtained at 8 
and 24 hr, and peaked at 48 hr (p<0.001, 
respectively) (Table 1 & Fig 1B). 
Non-significant difference was found between 
mean values of expression of either CD11b or 
CD64 in neonates with culture proven sepsis and 
those with sepsis but negative blood culture results: 
(at 24 hr, mean CD11b expression: 61.3±22.51% 
vs. 58.3±16.31%, respectively, p>0.05; mean CD64 
expression: 42.05±19.67% vs. 34.57±19.36%, 
respectively, p>0.05).   
Correlation study, at the 4 serial measurements, 
revealed that among study neonates the expression 
of both neutrophil-surface antigens was not 
significantly correlated (p>0.05) with either 
gestational age or birth weight. Similarly, non-
significant correlations were also found between 
each of CD11b and CD64, and the corresponding 
hematological scores and serum CRP levels at the 4 
serial measurements (p>0.05, respectively). 
Diagnostic performance test results for 
determination of the best cut-off value of CD11b 
and CD64, at 8, 24 and 48 h, for prediction of early-
onset sepsis are presented in Table (2) & Fig (2). 
Expression of CD11b at a cut-off value of  35% at 
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24 h was the best for prediction of early-onset 
sepsis with 80% sensitivity, 100% specificity and 
91% efficacy. CD64 expression at a cut-off  value 
of 17% at 24 h had also the best diagnostic 
performance for sepsis prediction with 88% 
sensitivity, 90.3% specificity and 89.3 % efficacy. 
Combined use of both markers, at 24 h, resulted in 
improvement of prediction value with 90% 
sensitivity, 95% specificity and 93 % efficacy (Fig 
3).       
Time course of expression of mean percentages 
of CD11b and CD64 during the first 48 hours in 
relation to sepsis outcome are shown in Table (3) & 
Fig (4). Significantly lower mean CD11b 
expression was predictive of favorable outcome 
(survival) as early as 8 h and onwards compared to 
mean values in those who had fatal outcome 
(p<0.001, respectively). Significantly lower mean 
CD64 expression was evident in survivors at 24 h, 
as compared to non-survivors (p<0.001). Data were 
missing for non-survivors at 48 h. 
Diagnostic performance test results for 
determination of the best cut-off value of CD11b 
and CD64 for prediction of mortality are shown in 
Table 4. At 24 h, expression of CD11b at a cut-off 
value of 88% and CD64 at a cut-off value of 50% 
had the best utility for prediction of mortality with 
















 0 h                                   8 h                               24 h                            48 h 
Fig I : Serial flow cytometric analyses of CD11b (A) and CD64 (B) expression by peripheral blood   















 0 h                                   8 h                               24 h                            48 h 
Fig II : Serial flow cytometric analyses of CD11b (A) and CD64 (B) expression by peripheral blood   
neutrophils of a non-infected (non-septic) neonate at  0, 8, 24 and 48 h. 
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Fig 1: Mean levels of expression of CD11b (A) and CD64 (B) in septic versus non-septic neonates during 












































CD11b-8h      0.853 
CD11b-24h     0.907 
CD11b-48h     0.639 
 
3BAUC 
1BCD64-8 h      0.569 
CD64-24h      0.844 
CD64-48h      0.810 
(A) (B) 
AUC: area under curve 
Best cut-off is indicated by the shaded mark. 
 
Fig 2: Receiver operator characteristic (ROC) curve analysis for diagnostic performance of CD11b (A) 








































CD11b-24h  0.907 
0BCD64-24h                   0.844 
Multi  0.920 
AUC: area under curve 
Best cut-off is indicated by the shaded mark 
 
Fig 3: Multi-ROC curve analysis for the diagnostic performance of combined CD11b and CD64 at 24 h 
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Data were missing for non-survivors at 48 h. 
 
Fig 4: Mean levels of expression of CD11b (A) and CD64 (B) in survivors versus non-survivors during 
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Table 1: Levels of neutrophil cell-surface antigen expression at 0, 8, 24 and 48 h: 
comparison between septic and non-septic neonates 
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 p<0.05: significant;  p <0.01& p <0.001:highly significant; p >0.05: non-significant; SD: standard deviation. 
 
Table 2: Diagnostic performance test results of CD11b and CD64 for prediction of  
early-onset neonatal sepsis (sepsis or no infection). 
 CD11b CD64 
Time 8 h 24 h 48 h 8 h 24 h 48 h 
Best cut-off value (% of cells) 34 35 28 10 17 15 
Sensitivity (%) 82.14 80.0 90.48 92.86 88 100 
Specificity (%) 96.77 100 54.84 67.74 90.32 80.65 
Positive prediction (%) 95.83 100 57.58 72.22 88 77.78 
Negative prediction (%) 85.71 86.11 89.47 91.30 90.32 100 
Efficacy (%) 89.83 91.07 69.23 79.66 89.29 88.46 
 
Table 3: Levels of neutrophil cell-surface antigen expression at 0, 8 and 24 h*: comparison 
between sepsis survivors and non-survivors. 






























































*Data were missing for non-survivors at 48 h.  
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Table 4: Diagnostic performance test results of CD11b & CD64 for  
prediction of sepsis outcome (survivors versus non-survivors) 
 CD11b CD64 
Time 8 h 24 h 8 h 24 h 
Best cut-off value (% of cells) 77 88 19 50 
Sensitivity (%) 100 100 14.29 100 
Specificity (%) 95.24 100 90.48 100 
Positive prediction (%) 87.5 100 33.33 100 
Negative prediction (%) 100 100 76 100 
Efficacy (%) 96.43 100 71.43 100 
 
DISCUSSION 
An early laboratory marker that can reliably predict 
neonatal sepsis with high sensitivity and specificity 
remains a continuing challenge to the clinician15. 
There is a growing interest in the use of granulocytic 
surface markers for the diagnosis of some inherited 
and acquired disorders16,17. Data concerning their use 
as markers for prediction of neonatal sepsis are 
infrequently reported in the literature.  
Our findings revealed an enhanced expression of 
both CD11b and CD64 antigens by peripheral blood 
neutrophils within the first 48 hours of postnatal life 
in neonates with early-onset sepsis in comparison to 
non-infected neonates. These results were in 
agreement with those obtained by several other 
investigators18,19,20. They assumed that these markers 
can predict sepsis by providing a means to 
distinguish infected neonates, at a very early time 
point of infection before clinical evidence, from 
suspected, but non-infected, neonates. 
In our study population, prematurity associating 
prolonged premature rupture of membranes (PROM) 
was the dominant risk factor for the development of 
early-onset neonatal sepsis. This was revealed by the 
lower mean gestational age and birth weight of septic 
neonates compared to non-septic neonates. PROM 
specially if associated with prematurity had been 
previously mentioned as the most important risk 
factor of sepsis, thus neonatal infection results from 
vertical transmission of microorganisms from 
infected maternal birth canal to the preterm who had 
relatively deficient immune responses3,4.  
It has been previously described that the 
expression of cell-surface activation markers by 
neutrophils is under developmental control, being 
down-regulated in preterm when compared with term 
infants and adults21,22. If this is the case, the dominant 
prematurity of the septic group in our study would 
have resulted in lower, rather than the encountered 
significantly higher, expression level of both 
neutrophil surface activation markers. It is worth 
mentioning, however, that gestational age was 
unlikely related to the observed variations in the 
expression of CD11b and CD64 by neutrophils as the 
levels of expression of both markers were not 
correlated with the gestational age. Similar 
observation of lack of influence of gestational age on 
CD11b expression was previously reported23. 
Moreover, it was mentioned that the  increased 
expression of neutrophil-surface antigens occurs only 
upon cell activation24.  
An early onset of enhanced CD11b expression, 
in septic neonates of the present study, was 
detectable in cord blood (0 h).  CD11b approached 
near two-fold its mean level in non-infected neonates 
at 8 h, was sustained at 24 h, and started to decline 
thereafter. The enhanced CD11b expression in 
response to infection was previously mentioned by 
several investigators10,25 who explained that in the 
resting neutrophils 95% of their total content of 
CD11b occurs as membrane components of specific 
granules and secretory vesicles, i.e. as intracellular 
storage granules, with only 5% of CD11b content 
expressed on cell surface. When stimulated, 
exocytosis of these secretory vesicles takes place 
resulting in enhanced CD11b expression. The 
subsequent decline demonstrated at 48 h may reflect 
the early down-regulation of neutrophil activation 
prior to the resolution of an ongoing infection. 
Weirich et al18 and Nupponen et al20 found an 
increased expression of CD11b in neonatal sepsis 
that seemed superior to CRP in the detection of 
inflammation at its early stage. The same findings 
were also confirmed by El-Kerdani et al23 and 
Khazbak et al26 who suggested that CD11b is 
normally expressed at a low level on  the surface     
of neonatal non-activated  neutrophils.  Its     
expression on neutrophil cell surface, however, 
increases substantially  within a few  minutes after 
the cell comes in contact  with  bacteria or  
endotoxins  thus  it could be superior to CRP and  the     
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hematological scoring system in the early detection 
of neonatal sepsis.   
Regarding neutrophil CD64 surface antigen, an 
enhanced expression was first detectable in the 
sepsis group of the present study at 8 h with high 
specificity, but at a very low sensitivity. However, 
the mean percentage of CD64 expression in the 
sepsis group approached four-fold the 
corresponding mean in non-infected group at 24 h 
where the best diagnostic sensitivity and specificity 
were obtained by that time. Similar results of 
enhanced expression CD64 in bacterial infection 
were previously obtained19. It was explained that 
CD64, the high affinity Fcγ receptor I, which is 
involved in the process of phagocytosis and 
intracellular killing of pathogens27 is also expressed 
at a low level on the surface of un-stimulated 
neutrophils19. During bacterial infection, the 
expression of CD64 on activated neutrophils is 
markedly increased28,29. 
Fjaertoft and associates19 found that in a small 
series, the expression of CD64 was significantly 
enhanced in infected newborns as compared to 
healthy counterparts. It was also reported that 
neonates with proven late-onset sepsis or clinical 
signs of sepsis had an increased percentage of 
CD64 positive cells, indicating that the level of 
expression of this antigen may be a specific in vivo 
marker of neutrophil activation and strongly 
suggest the presence of infection which would 
indicate the necessity of antibacterial 
administration30. Ng and coworkers31 had also 
raised the high sensitivity value of neutrophil CD64 
expression in the diagnosis of late-onset nosocomial 
infection in the very low birth weight (VLBW) 
infants. Another group of investigators found that 
CD64 expression was elevated in most survivors 
and non-survivors of septic shock as compared to 
non-septic adult patients32. 
Diagnostic performance tests of CD11b and 
CD64 for prediction of early-onset sepsis revealed 
that both markers had their best performance at 24 
h. By that time, CD11b expression at a cut-off value 
of 35% (80% sensitivity, 100% specificity and 91% 
efficacy) and CD64 expression at a cut-off  value of 
17% (88% sensitivity, 90.3% specificity and 89.3% 
efficacy) were the best for prediction of early-onset 
sepsis. Combined use of both markers, at 24 h also, 
resulted in improvement of prediction value with 
90% sensitivity, 95% specificity and 93% efficacy.       
The enhanced expression of CD11b and CD64 
neutrophil markers in our series did not correlate 
with the serum CRP concentration. Both markers 
were superior to the latter in prediction of early-
onset sepsis as serial concomitant measurements of 
serum CRP revealed a very low early diagnostic 
value with a sensitivity of only 3.6% at 8 h and 
40% at 24 h for sepsis prediction. A gradually 
increasing diagnostic sensitivity of CRP during the 
coarse of septicemia was also shown previously.33 
Kuster et al34 had emphasized that CRP is of limited 
use in early detection of sepsis. It remains normal at 
the onset and after 8 hours of invasion by 
pathogenic bacteria, but may become apparent 
within 24 hours, which goes with the findings of 
our study. This lag period between the triggering 
factors and the onset of a positive CRP result, 
renders a single measurement of very limited early 
diagnostic value. Serial CRP measurements are 
useful for monitoring the course of sepsis and the 
response to antibiotics35.     
An additional question of importance was that 
whether the enhanced expression of these 
neutrophil-surface markers is related to the severity 
of systemic inflammation and sepsis outcome. It 
was previously mentioned that the enhanced CD11b 
expression, serving as an activation marker of 
neutrophils, is related to the severity of systemic 
inflammatory response syndrome in acutely ill 
adults36,37,38 and may predict organ failure in 
patients with septic shock37. It was also shown that 
newborn infants who had the highest levels of 
CD11b expression in a setting of early-onset 
streptococcal sepsis, died with fulminant sepsis at 
the age of 3 days20. In concert, our findings also 
revealed that CD11b and CD64 are related to the 
severity of systemic inflammation and, 
subsequently, to the outcome. Septic neonates who 
demonstrated the highest levels of expression of 
both markers at 8 and 24 h died shortly-after within 
the age of 48 h. In this respect, CD11b was superior 
to CD64 as a predictor of the outcome as early as 8 
h with 100% sensitivity and 95.2% specificity. 
CD64 demonstrated the best prognostic utility as an 
indicator of mortality at 24 h with 100% value for 
both sensitivity and specificity. On the contrary, 
Muller and coworkers39 found that poor prognosis 
in critically ill patients with sepsis was associated 
with a lower expression of some activation markers 
on monocytes and neutrophils suggesting that poor 
outcome may be due to a compensatory anti-
inflammatory response. 
Finally, it could be concluded that the 
expression of the neutrophil activation markers 
CD11b and CD64 could be a reliable tool for early 
prediction and prognosis of early-onset sepsis in the 
suspected neonate, irrespective to other laboratory 
results and before the evolution of clinical signs. 
Although CD11b showed earlier predictive and 
prognostic values, both markers had their best 
CD11b and CD64 expression in neonatal sepsis. 
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utility, especially when combined, at 24 hours of 
life. This may be of a significant importance for 
therapeutic decision-making in neonates suspected 
for early-onset infection. Thus, they might indicate 
the necessity of early initiation of antibiotic 
treatment for sepsis, with corresponding 
improvement of the outcome, and reduce the 
unnecessary use of antimicrobials in non-infected 
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